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As part of a current worldwide effort to understand the physiology of human BAT (hBAT) and whether its
thermogenic activity can be manipulated to treat obesity, the workshop ‘‘Exploring the Roles of Brown Fat
in Humans’’ was convened at the National Institutes of Health on February 25–26, 2014. Presentations and
discussion indicated that hBAT and its physiological roles are highly complex, and research is needed to
understand the health impact of hBAT beyond thermogenesis and body weight regulation, and to define
its interactions with core physiological processes like glucose homeostasis, cachexia, physical activity,
bone structure, sleep, and circadian rhythms.Introduction
More than 60 years of studies in rodent models have shown that
the presence and activation of brown adipose tissue (BAT) via
cold stimulation or b3-adrenergic receptor (AR) treatment pro-
vides significant health benefits for experimental animals (Harms
and Seale, 2013). Although observed many decades ago in
cadaver tissues from winter outdoor workers (Huttunen et al.,
1981), it is only more recently that BAT has been consistently de-
tected in living adult humans (Nedergaard et al., 2007). This has
led to a concerted effort worldwide to understand the physiology
of human BAT (hBAT) and to investigate whether its thermogenic
activity can bemanipulated to treat metabolic disease. As part of
this effort, a workshop titled ‘‘Exploring the Roles of Brown Fat
in Humans’’ (http://www.niddk.nih.gov/news/events-calendar/
Pages/HumanBAT-2013.aspx) was convened at the National In-
stitutes of Health (NIH) by the National Institute of Diabetes and
Digestive and Kidney Diseases (NIDDK) on February 25–26,
2014. The meeting brought together 180 renowned investigators
from around the world to discuss state-of-the-art technology for
monitoring hBAT mass and activity, to present recent discov-
eries in the cell biology and endocrine pathways associated
with BAT, and to showcase clinical data of hBAT and its implica-
tions in metabolic studies.
Much of the interest in hBAT has been driven by the hope that
it represents a novel, easily assessable target for the treatment of
obesity (Bachman et al., 2002). There were several widely held
ideas about BAT that supported this concept, that now appear
simplistic and limiting given the emerging state of knowledge.
First, the original evidence for functional adult hBAT came from
the detection of bilaterally symmetric patches of intense radiola-
beled glucose uptake in the neck and supraclavicular region in
some oncology patients during diagnostic 18F-fluorodeoxyglu-
cose positron emission tomography/computed tomography
(18F-FDG PET/CT) scans that could be suppressed by warming
the patient. After confirmation in healthy adults, a positive 18F-
FDG PET/CT scan quickly came to define the presence of
hBAT. Second, from rodent studies it was known that BAT is a
form of ‘‘good fat’’ in which uncoupling protein 1 (UCP1) is acti-408 Cell Metabolism 20, September 2, 2014 ª2014 Elsevier Inc.vated in response to cold in order to facilitate a high rate of fuel
oxidation and heat production. Therefore, it seemed appropriate
to posit that the primary stimulus for hBAT activation is via cold
temperature sensing, and that its physiologic role is thermogen-
esis. Third, although abundant in newborn babies and detect-
able upon cold stimulation with 18F-FDG PET/CT in some young
lean adults, hBAT appeared to be missing in obese and elderly
people using this method of detection. This lack of hBAT could
perhaps underlie a state of metabolic efficiency that supports
excess fat deposition, and restoration and activation of hBAT
through pharmacologic or environmental means could then be
a route to reduce obesity.
Presentations and discussion at the recent NIH hBAT work-
shop indicated that each of these concepts is too simple to
explain newer observations, and that additional research is
needed to elucidate the likely more complex physiological roles
of hBAT. Research in humans is still limited by the paucity of
available noninvasive tools that can quantify the mass, activity,
and potential for activation of hBAT in all its forms, but efforts
to develop suchmethods that synergizewith emerging biological
information are quickly gaining momentum.
At the conclusion of the workshop, an engaging open-floor
dialog among the participants was held. The following summary
represents the principal concepts that arose from that discus-
sion and identifies unanswered questions, unmet needs, and
some critical areas of future research.
The Definition of Human BAT Is Evolving
For the purposes of clarity, the term ‘‘BAT’’ will be used in this
document to refer to any region of fat that contains UCP1-posi-
tive adipocytes. Currently, in adult humans, this includes tissue
in the neck, above the clavicles, and along the spine that can
be visualized using 18F-FDG PET/CT. There are at least two
known types of brown adipocytes in BAT as well as white adipo-
cytes in varying proportions. Data frommultiple laboratories indi-
cate that in rodents, brown adipocytes derive from two distinct
mesenchymal lineages. Brown adipocytes found in the rodent in-
terscapular and perirenal regions share an origin with myocytes
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brown adipocytes have been called ‘‘brown,’’ ‘‘classical,’’ or
‘‘constitutive,’’ and in this document the term ‘‘classical brown
adipocyte’’ will be used. A second type of brown adipocyte
arises in rodent white adipose depots in response to stimuli
such as sympathetic activity during cold acclimation, chronic
administration of b3-AR agonists, or exercise, and may share
a developmental origin with white adipocytes. These brown adi-
pocytes have been called ‘‘beige,’’ ‘‘brite’’ (for ‘‘brown-like in
white’’), ‘‘inducible,’’ or ‘‘recruitable.’’ Presently, it is not settled
what the preferred nomenclature will be for this second type of
brown adipocyte, but they will be called ‘‘beige adipocytes’’ in
this document. Both cell types are polygonal with central nuclei,
multilocular lipid droplets, a high mitochondrial content, and
contain UCP1, but each type has a distinct gene expression pro-
file (Harms andSeale, 2013). Humanbrown adipocytes fromboth
lineages have been documented in biopsied fat from the human
neck, supraclavicular, and interscapular regions. As data
continue to accrue, it seems likely that most, if not all, adult hu-
mans have some mature brown adipocytes from both lineages,
and there may be several phenotypically distinct subtypes (Lee
et al., 2011; Wu et al., 2012; Sharp et al., 2012; Cypess et al.,
2013; Jespersen et al., 2013).
A few more definitions are needed. All brown adipocytes can
be ‘‘activated,’’ meaning that they have UCP1 that can be
turned on in response to sympathetic stimuli such as cold, re-
sulting in heat production. Activation is proportional to a
thermic challenge, such that these tissues are partially acti-
vated even at ambient temperature (Cohen et al., 2014). In addi-
tion, brown and beige adipocytes can be ‘‘induced’’ in rodents
in response to sympathetic stimuli, such that new adipocytes
arise from tissue-resident stem/progenitor cells resulting in an
increase in the number of brown adipocytes. In humans, evi-
dence is accumulating showing that hBAT tissues in the neck
are plastic and can therefore be induced (Huttunen et al.,
1981; Blondin et al., 2014; Lee et al., 2014a, 2014b; van der
Lans et al., 2013). In mice, this ‘‘browning’’ can also be
observed in subcutaneous fat depots (Young et al., 1984; Wu
et al., 2012). It remains unknown whether humans, like rodents,
have the potential for appreciable induction of beige adipocyte
mass in depots outside of the neck, supraclavicular, and
thoracic depots noted in 18F-FDG PET/CT scans, although
one observation has been made in a patient treated with thyroid
hormone (Skarulis et al., 2010). If browned white fat is
commonly found in people, it will be difficult to investigate all
the biological, behavioral, and environmental triggers for such
‘‘subcutaneous inducible brown adipose tissue’’ (siBAT) until
noninvasive or minimally invasive means to measure its mass
and activity are developed. It will be important to determine if
there is a correlation between the presence of BAT and siBAT,
and if their functions are distinct.
The present discussion is focused on the hBAT depots that
can currently be detected, in order to explore their mass and
function in normal human health and disease, and to inform ef-
forts to target them therapeutically. Given the current early state
of knowledge, it is likely not crucial to develop technologies that
can distinguish between human classical brown and beige adi-
pocytes. It is, however, very important to understand if hBAT,
whether in the neck/subclavicular regions or in subcutaneouswhite depots, can be induced to dramatically increase the poten-
tial for therapeutic thermogenesis.
18F-FDG-PET/CT Is Informative but Not Sufficient
Central to gaining a better understanding of hBAT physiology
is the proper application of noninvasive whole-body imaging.
While 18F-FDG-PET combined with CT has been instrumental
in advancing our understanding of hBAT over the past decade,
it is becoming apparent that this technique by itself provides
an incomplete picture of hBAT morphology and metabolic activ-
ity, and could at times even be misleading. There are several
well-recognized limitations to 18F-FDG-PET/CT. First, while the
standard uptake value (SUV) of the radiolabeled glucose analog
accurately reflects glucose uptake into metabolically active tis-
sues, when a tissue such as BAT is inactive or weakly activated,
it remains largely invisible. The intensity of the FDG-PET signal is
a function of the extent of hBAT activation, and individuals sub-
jected to the same cold stimulus may not respond the same.
Second, even when PET time and activity curves are collected
and calibrated using arterial blood 18F-FDG-specific activity,
the resultant measure of glucose uptake is not necessarily a
quantitative reflection of hBAT thermogenesis. Although plasma
glucose is taken up upon hBAT activation, the initial substrate is
believed to be endogenously derived fatty acids, followed by a
preference for circulating free fatty acids and triglycerides from
chylomicrons and VLDL. Therefore, glucose uptake measured
by 18F-FDG-PET likely underestimates BAT activity under phys-
iologically meaningful conditions such as mild cold.
On the other hand, glucose uptake into BAT can potentially
be increased by insulin without accompanying increases in ther-
mogenesis, local blood flow, and UCP1 activation, and can
therefore be a poor measure of thermogenesis, particularly in
postprandial and disease states (Orava et al., 2011). It should
be emphasized that in addition to its role as a fuel for oxidation,
glucose is a substrate for other processes such as anaerobic
glycolysis, lipogenesis, and anaplerosis. These processes are
not necessarily linked to thermogenesis, and 18F-FDG-PET/CT
is currently not able to distinguish among these different path-
ways of glucose utilization. Thus, while it was agreed that
18F-FDG uptake as observed in 18F-PET/CT images can indicate
the presence of metabolically active hBAT (e.g., high sensitivity),
it is not a definitive imaging biomarker (e.g., low specificity) for
hBAT presence and thermogenesis.
Another recognized limitation of 18F-FDG-PET/CT that
emerged from discussion among workshop participants was
the difficulty of quantifying BAT glucose uptake in the presence
of many confounding factors. For example, the PET SUV
endpoint is affected by the amount and rate of glucose uptake
into other tissues and organs, the dosage administered, the
subject’s weight and fat percentage, prandial state, radiotracer
specific activity, partial volume effects, and the glucose uptake
kinetics in BAT. Estimates of SUV and activated tissue volume
are dependent on the specific parameters chosen for the exper-
iment and analysis, and can vary from one observer to another.
One possible approach toward more meaningful measurements
is to employ quantitative dynamic PET methods combined with
modeling of the imaging data by graphical analysis.
Lastly, PET/CT is relatively expensive and involves significant
exposure of a subject to ionizing radiation beyond minimal risk,Cell Metabolism 20, September 2, 2014 ª2014 Elsevier Inc. 409
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infants and children, and healthy cohorts. While 18F-FDG PET/
CT has arguably advanced our understanding of hBAT physi-
ology over the past decade, the modality alone should not be
considered a gold standard for characterizing hBAT properties,
including mass, thermogenesis, and the potential for activation.
Novel hBAT Detection Methods Are under Development
A variety of physiological, biochemical, andmetabolic features of
hBAT can be exploited to provide signal contrast, and monitored
with available imaging and biosensor methods (for reviews, see
Bauwens et al., 2014 and Hu and Kan, 2013). For example, mag-
netic resonance imaging (MRI) and CT can measure fat fraction
and thereby identify BAT, since the fat content of brown adipo-
cytes is different than that of lean muscle and lipid-rich white ad-
ipocytes (Hamilton et al., 2011; Chen et al., 2013b; Baba et al.,
2010). hBAT is densely permeated by capillaries and sympathetic
neurons that participate in its unique function. The change in
blood flow that occurs upon cold-stimulated sympathetic activa-
tion can be imaged using PET, MRI, or ultrasound andmay serve
as a surrogate for tissue thermogenesis (Orava et al., 2011;
Khanna and Branca, 2012; Clerte et al., 2013). PET tracers
have been produced that can bind to the neurotransmitter norepi-
nephrine transporter (Lin et al., 2012) or read the changes inmito-
chondrial membrane potential that occur upon tissue activation
(Madar et al., 2011). A sampling of BAT detection methods was
presented at the workshop, and Table 1 lists detection methods
under development along with the biological feature of BAT that
each measures. Many were developed with support from RFA-
DK10-002 in 2010, ‘‘Human Brown Adipose Tissue: Methods
for Measurement of Mass and Activity’’ (http://grants.nih.gov/
grants/guide/rfa-files/RFA-DK-10-002.html). A majority of these
methods are still in their infancy. Most of them have yet to be vali-
dated in people, remain cost prohibitive, and have yet to reach
widespread availability among the research community.
It will be highly advantageous to have a substantial menu of
validated tools for the study of hBAT. Some of these tools will
detect properties that correlate with tissue mass but not its acti-
vation state. Other methods will detect only activated tissue,
while others will yield information about both the mass and the
thermogenic activity of BAT. Some are quantitative, while others
are extremely sensitive but cannot yield absolute values for mass
or heat production. It became apparent during workshop discus-
sion that no single modality or technique currently exists to
comprehensively characterize BAT morphology and measure
its mass and activity, and a combination of techniques is likely
to be more informative than any single entity alone. Even within
a single modality such as magnetic resonance, a suite of com-
plementary spectroscopy and imaging experiments sensitive
to either tissue mass and morphology (fat fraction) or function
(blood flow) should be compiled to fully characterize hBAT
mass and metabolic activity. The emerging fusion modality of
PET/MR is progressively becoming available at research institu-
tions worldwide and was acknowledged at the workshop as a
very promising multitool platform that can potentially provide a
‘‘one-stop shop’’ for elucidating hBAT properties within a single
examination.
It is hoped that tests intended for widespread use in the clinic,
for large epidemiological studies or for drug development, will be410 Cell Metabolism 20, September 2, 2014 ª2014 Elsevier Inc.inexpensive, be noninvasive, and take advantage of technology
that is widely available. Measurements designed for use in free-
living individuals could yield important insight into tissue func-
tion. For example, although it is difficult to translate temperature
into quantitative measures of thermogenesis, radiometers that
are sensitive to tissue temperature may offer the advantage of
portability and home-based usage. When coupled with telem-
etry, radiometers could be used to estimate hBAT thermogene-
sis in large populations, to monitor the effects of climate and
other environmental stimuli, and to investigate circadian re-
sponses (Arunachalam et al., 2008; Rodrigues et al., 2013). Ulti-
mately, comparative studies will be needed to identify the
strengths, limitations, and cost effectiveness of the most prom-
ising technologies. It is hoped that researchers will soon be able
to assemble suites of complimentary techniques that at a mini-
mum provide independent measures reflective of hBAT mass
and activity, and that are tailored for use in different experimental
and clinical environments.
StandardizedProtocols AreNeeded for hBATActivation,
Detection, and Reporting of Results
Workshop participants felt that additional concrete steps should
be taken by the research community to enhance the reproduc-
ibility, repeatability, accuracy, and precision of hBAT measure-
ments. In particular, there is an immediate need to develop
minimum standards for 18F-FDG-PET/CT data acquisition and
operator-independent image analysis (for instance, see Chen
et al., 2013a) so that the tissue volume and intensity of tracer up-
take from different laboratories can be compared (also sug-
gested by Bauwens et al., 2014 and van der Lans et al., 2014).
Likewise, as each emerging method is developed and validated,
guidelines for parameters used, andminimum standards for data
acquisition, analysis, and literature reporting should be estab-
lished. It was also noted that sharing of validated experimental
protocols in a common repository is one way that multi-institu-
tional collaboration and consensus can be stimulated. Since
exposure of humans to cold temperatures is likely to continue
to be one way researchers maximally activate hBAT for mea-
surement of its volume, at numerous times during the 2 day
meeting there was a call to standardize the cold-exposure proto-
cols. The spectrum of existing valid approaches for cold stimu-
lation of people presently include the use of climate-controlled
rooms, water-circulating vests, and exposure of a limb to cold
water. Some groups rely on exposure to a fixed temperature,
while others use a personalized cooling protocol in which a sub-
ject is cooled to shivering, then warmed slightly (van der Lans
et al., 2014). Such differences in the cooling goals likely affect
the degree of BAT activation and therefore the ability to detect
it, and any quantitative measure of thermogenesis. This makes
it difficult to comparemeasures of hBAT volume or maximal acti-
vation potential among individuals or across populations, and
should be addressed. The alternative of using pharmacological
agents to reliably activate hBAT was discussed (Broeders
et al., 2014). Hopefully as pharmacological agents and other
means that can easily, reliably, and reproducibly activate hBAT
become available, protocols using these agents will also be stan-
dardized. While such minimal standards are needed to compare
data regarding hBAT incidence, volume, and activation potential
across laboratories and populations, experimental parameters
Cell Metabolism
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question under study (Chen et al., 2013a).
The preceding discussion focused only on technologies for
monitoring hBAT. There are presently no approaches that can
noninvasively differentiate between classical brown and beige
adipocytes within hBAT, although molecular imaging with tar-
geted cell-specific probes may be a promising approach (Azh-
darinia et al., 2013). More importantly, there are no current
means other than histology of biopsied fat tissue to unambigu-
ously detect beige fat cells that are induced in subcutaneous
white fat depots. It seems unlikely that current imaging ap-
proaches will be useful in the short term in subcutaneous fat
depots, where the ratio of brown to white adipocytes is likely
to be very low under most circumstances. Perhaps circulating
plasma biomarkers (e.g., secreted adipokines or miRNAs) could
be found that reflect siBAT or total brown adipose mass or acti-
vation. These challenges were identified as critical unmet needs.
hBAT Thermogenesis Can Directly Affect Energy
Expenditure, but the Potential to Impact Body Weight
Is Less Clear
Therewas considerable discussion regarding the possible health
benefits of pharmacologic or environmental activation of hBAT at
the workshop. However, it remains to be seen whether excess
thermogenesis can be activated safely, and if the resultant in-
crease in energy expenditure is sufficient to affect weight or
metabolic health. Estimates of potential maximal thermogenesis
of cold-induced hBAT lie between 25 and 400 kcal/day in lean
people (Muzik et al., 2013; Yoneshiro et al., 2011), but it has
proven difficult to date to achieve high levels of activation with
cold in obese people using a number of different time courses
and cooling protocols (Orava et al., 2013). However, if brown
fat cell mass in classical BAT or subcutaneous white fat depots
can be induced in people, as has been observed in rodents
(Schulz and Tseng, 2013), it may be possible to greatly increase
the thermogenic potential of whole-body hBAT. This could then
change the emphasis of obesity treatment research from finding
a safe means of activating existing hBAT, to inducing brown fat
cell adipogenesis in multiple fat depots, particularly using agents
other than cold exposure (Kajimura and Saito, 2014; Bonet et al.,
2013). However, even if increased hBAT mass and activation
state were achievable, the increase in energy expenditure is still
likely to be less than that seen with even moderately intense ex-
ercise programs, which in isolation have not been effective for
weight loss. Workshop participants speculated that, like exer-
cise, sustained hBAT activation may even trigger a homeostatic
response to increase calorie intake (Cannon and Nedergaard,
2009). However, either sustained or transient increases in
hBAT mass and/or activity could potentially be used to protect
against weight gain or help maintain weight loss, and prevent
metabolic diseases such as diabetes. Whether hBATmodulation
is a good target for treating obesity and preventing diabetes will
require more research on large populations.
hBAT Has Health Benefits Beyond Its Important Role in
Energy Balance and Cold Tolerance
Several talks and poster presentations at the NIH hBAT work-
shop touched on a number of physiological processes that
appear to be regulated in some way by BAT. Beyond cold toler-ance, BAT likely plays a protective role in metabolic health unre-
lated to weight modulation. These include potential involvement
in regulating glucose homeostasis and insulin resistance (re-
viewed by Peirce and Vidal-Puig, 2013), liver steatosis, blood
lipids, cardiovascular health and disease, and immune system
health. Beige fat cells appear to have an impact onwhite adipose
tissue health; in mice, subcutaneous white adipose depots that
lack PRDM16 and therefore cannot increase brown adipocyte
number contain higher levels of fat, activated macrophages,
and inflammatory markers (Cohen et al., 2014). hBAT mass
and activity appear to be integrated with the health and function
of bone in adults (Bredella et al., 2014), and with skeletal muscle
mass in babies, children, and adolescents (Ponrartana et al.,
2013). BAT is a primary source of heat in torpor/arousal transi-
tions in hibernating rodents (Hindle and Martin, 2014) and in re-
covery from sleep deprivation in mice (Szentirmai and Kapa´s,
2014). Its role in circadian rhythms and sleep regulation in hu-
mans has yet to be investigated. Lastly, rodent studies have
shown that multiple peptides from different organs induce the
growth and activation of brown adipocytes, including FGF-21
from liver; atrial natriuretic peptide from heart; and irisin, myosta-
tin, and TGF-b from skeletal muscle (Kajimura and Saito, 2014).
In turn, BAT may secrete signaling factors that communicate
back to other tissues (Villarroya et al., 2013), again suggesting
that regulated crosstalk between a number of tissues and BAT
is important for maintaining health.
More research is needed to understand the impact of hBAT
beyond thermogenesis, and to define the interactions between
hBAT and several core physiological processes: prandial states,
anorexia, cachexia, physical activity, bone structure, sleep,
circadian rhythms, and aging. Prospective and longitudinal
studies are necessary to address these fundamental unknowns.
Research on the basic biological properties of hBAT is in its in-
fancy, and many questions remain to be asked, such as whether
it has an endocrine role, and how it interacts with other signaling
tissues. Based on the results presented at the workshop, partic-
ipants were optimistic that strategies targeting hBAT induction
and activation could help to prevent weight gain, maintain weight
loss, protect against the complications of obesity such as fatty
liver and cardiovascular disease, improve glucose homeostasis
in diabetes, and enhance overall metabolic, bone, and skeletal
muscle health.
Conclusion
We are only beginning to understand the beneficial roles for adult
hBAT. Our ability to conduct experiments depends on finding a
combination of validated, minimally invasive technologies that
can independently measure tissue mass and accurately quanti-
tate thermogenesis capacity. An impressive array of imaging and
thermometry approaches are emerging, and as they are vali-
dated these should be combined in order to provide a rich pic-
ture of hBAT mass and function. To date it is not known whether
human peripheral white fat depots can be browned, and if so
there will be a need for noninvasive measures that will allow
this siBAT to be studied. Due to the expected low brown-to-
white adipocyte ratio, it is likely that circulating molecules or
other indirect biomarkers will be more useful than imaging
approaches to detect siBAT. It would be advantageous if re-
searchers could agree on a minimum set of guidelines regardingCell Metabolism 20, September 2, 2014 ª2014 Elsevier Inc. 411
Table 1. Summary of Methods to Detect Human Brown Adipose Tissue (BAT)
Imaging Target and
Measured Parameter Modality Basis of Signal
Primary
Endpoint: BATa
Mass or Function Unique Features Challenges References
Glucose uptake PETb 18F-fluorodeoxyglucose Function Widely available and
employed
Ionizing radiation Nedergaard et al., 2007;
Virtanen et al., 2009;
Mirbolooki et al., 2014g
Negligible uptake in
inactive BAT
Large signal increase
upon BAT activation
Unknown correlation with
thermogenesis
Lack of standardization
Fatty acid or Acetate
uptake
PET 14(R,S)-18F-fluoro-6-
thiaheptadocanoic acid
Function Nutrients avidly taken up
by activated BAT
Ionizing radiation Ouellet et al., 2012
11C-acetate Large signal increase
upon BAT activation
Negligible uptake in
inactive BAT
Limited validation
Mitochondrial
respiration
PET Locally produced H2
15O from
inspired 15O2
Function Visible only in metabolically
active tissues
Ionizing radiation Muzik et al., 2013g
Large signal increase upon
BAT activation
Negligible uptake in
inactive BAT
Quantitative measure of
thermogenesis
Limited validation
Mitochondrial
membrane potential
PET 18F-flurobenzyl triphenyl
phosphonium (FBnTP)
Mass and
function
Tracer mitochondria
accumulation: inactive
BAT>> muscle or WAT
Ionizing radiation Madar et al., 2011g
Signal reduced in active BAT Limited validation
Quantitative
Norepinephrine
transporter protein (NET)
PET (S, S)-[11C] O-methylreboxetine
([11C] MRB)
Mass High baseline signal in
inactive BAT
Ionizing radiation Lin et al., 2012g
Signal only mildly affected
by BAT activation
Limited validation
Tissue fat content MRc (imaging) Chemical-shift 1H water-fat
separation
Mass No ionizing radiation (MR) Cannot readily distinguish
inactive and active BAT
Hamilton et al., 2011g;
Chen et al., 2013bg
Dixon method Quantitative measure of
BAT morphology (e.g. fat
content), BAT has lower
fat content than WAT
Fat content not a unique
signal feature of BAT
CTd Tissue X-ray attenuation
(Hounsfield units)
Ionizing radiation (CT) Baba et al., 2010;
Hu et al., 2011g
Intracellular water-fat
molecular interactions
MR
(spectroscopy)
Intermolecular zero quantum
coherence- spatial proximity
of water and fat molecules
Mass Signal unique for BAT Limited commercial
availability
Branca et al., 2013ag
(Continued on next page)
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Table 1. Continued
Imaging Target and
Measured Parameter Modality Basis of Signal
Primary
Endpoint: BATa
Mass or Function Unique Features Challenges References
Long data acquisit n time
MR resonance frequency
is temperature sensitive
Sensitivity to tissue
temperature (e.g., BAT activity)
Not yet validated in umans
129Xenon MR (imaging and
spectroscopy)
Hyperpolarized 129xenon
gas
Mass and
function
129Xenon gas dissolves in
highly perfused lipid-rich BAT
Limited commercia
availability
Branca et al., 2013bg;
Branca et al., 2013c
MR resonance frequency
is temperature sensitive
Sensitivity to tissue
temperature (e.g. BAT activity)
Special equipment eeded
for hyperpolarizatio
Not yet validated in umans
Pyruvate metabolism to
bicarbonate and lactate
MR (imaging and
spectroscopy)
Hyperpolarized
[13C]1-pyruvate
Function Visible only in metabolically
active tissues
Limited commercia
availability
Lau et al., 2014
A direct measures of
mitochondrial oxidation
Special equipment eeded
for hyperpolarizatio
Not yet validated in umans
BAT vascularity and
blood flow
USe Echogenic microbubbles Function No ionizing radiation
(US, MR)
Ionizing radiation
(PET, SPECT)
Clerte et al., 2013g
PET, SPECTf H2
15O, 99mTc-
methoxyisobutylisonitrile
A direct measure of local
tissue blood flow and
perfusion (all)
MR methods requi large
signal change to d erentiate
from baseline mea rements
Orava et al., 2011;
Cypess et al., 2013
MR (imaging) Blood-oxygen-level-
dependent (BOLD) T2*
and functional imaging
Appreciable signal change
upon BAT activation (all)
Limited validation Khanna and Branca, 2012g;
Chen et al., 2013bg;
van Rooijen et al., 2013
Targeted molecular
probes specific to BAT
Near-infrared
fluorescence
imaging
Peptide probe selective for
BAT vascular endothelium
Mass and
function
Potential high specificity
for inactive and active BAT
Limited availability Azhdarinia et al., 2013g
Not yet validated in umans
Temperature-activated
BAT produces heat via
thermogenesis
Microwave
radiometry
Surface sensors detect
radiating heat emitted
from activated BAT
Function Highly portable, wearable
system that can potentially
be monitored by telemetry
Limited availability Rodrigues et al., 2013g;
Arunachalam et al., 2008
Infrared imaging Noninvasive, low cost Limited validation
Heat is generated
other tissues besid BAT
Symonds et al., 2012
aBAT, brown adipose tissue.
bPET, positron emission tomography.
cMR, magnetic resonance.
dCT, computed tomography.
eUS, ultrasound.
fSPECT, single photon emission-computed tomography.
gFunded by NIDDK in response to RFA-DK-10-002.
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Perspectiveimaging data procurement, analysis, and interpretation, and for
the experimental protocols for cold stimulation of hBAT so that
data can be compared across laboratories and across popula-
tions. It remains to be seen whether hBAT will be an effective
target for weight loss, yet emerging data indicate that this tissue
plays many important roles in human health. Continued research
on the cellular and molecular properties of hBAT is needed to
inform on its physiological functions and provide additional stra-
tegies for manipulating its mass and activity. Finally, prospective
longitudinal studies in human populations are needed to provide
a complete picture of its incidence and the environmental and
physiological stimuli that regulate its activity.ACKNOWLEDGMENTS
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